POTS Treatment: A Complete Guide to Managing Postural Orthostatic Tachycardia Syndrome

POTS (Postural Orthostatic Tachycardia Syndrome): The Complete Guide

If your heart races every time you stand up, if you’ve been told “it’s just anxiety” or “drink more water,” and if you feel like your body has turned against you – you may have Postural Orthostatic Tachycardia Syndrome (POTS). And you are far from alone.

POTS affects an estimated 1-3 million Americans, yet the average patient sees seven doctors over four to six years before receiving a correct diagnosis. It’s been dismissed, misdiagnosed, and trivialized for decades. That’s finally starting to change – in part because the post-COVID era brought a massive surge in new POTS cases that forced the medical community to pay attention.

This guide is in-depth by design. Whether you’ve just been diagnosed, suspect you have POTS, or are a clinician trying to understand this complex condition, we’ve gathered the evidence on what POTS is, why it happens, how it’s diagnosed, and – most importantly – what can actually be done about it.

What Is POTS, Exactly?

POTS is a disorder of the autonomic nervous system – the part of your nervous system that controls involuntary functions like heart rate, blood pressure, digestion, and temperature regulation. When you stand up, gravity pulls blood downward into your legs and abdomen. In a healthy person, the autonomic nervous system compensates within seconds: blood vessels in the lower body constrict, the heart rate increases slightly (10-15 bpm), and blood pressure remains stable. You don’t feel a thing.

In POTS, this compensation fails. The autonomic nervous system either doesn’t constrict blood vessels properly, overreacts with excessive adrenaline release, or both. The result: blood pools in the lower body, the brain senses reduced blood flow, and the heart compensates by racing – 30, 40, sometimes 60+ bpm above your resting rate, just from standing up. This isn’t just an inconvenience. It means every upright activity – standing in line, cooking a meal, taking a shower – becomes a cardiovascular challenge.

Diagnostic Criteria

The formal diagnostic criteria for POTS require:

• Heart rate increase of ≥30 bpm (or ≥40 bpm in adolescents aged 12-19) within 10 minutes of standing or head-up tilt
• Heart rate often exceeds 120 bpm upon standing
• Absence of orthostatic hypotension (blood pressure does NOT drop ≥20/10 mmHg – this distinguishes POTS from orthostatic hypotension)
• Symptoms present for ≥3 months
• Absence of other causes of tachycardia (dehydration, anemia, hyperthyroidism, medications, prolonged bed rest)

The Tilt Table Test

The gold standard diagnostic test involves being strapped to a table that tilts from horizontal to 60-80 degrees upright while continuous heart rate and blood pressure monitoring records your autonomic response. The test typically lasts 10-45 minutes. While it sounds simple, it can be profoundly unpleasant for POTS patients – reproducing all of their worst symptoms in a controlled setting. Some patients faint during the test, which is actually diagnostically useful.

An active standing test (also called a “poor man’s tilt table”) can also be performed in any doctor’s office: lie flat for 5 minutes, record heart rate and blood pressure, then stand and re-record at 2, 5, and 10 minutes. If your heart rate meets the criteria, this is sufficient for diagnosis without a formal tilt table test. Many POTS specialists now prefer the active standing test because it more closely replicates real-world conditions.

The Three Subtypes of POTS

POTS is not a single disease but a syndrome – a collection of symptoms with multiple underlying mechanisms. Understanding your subtype is important because treatment strategies differ. Many patients have features of more than one subtype, and subtypes can overlap or evolve over time.

Symptoms: Far More Than a Fast Heart Rate

If you ask most doctors what POTS is, they’ll say “your heart rate goes up when you stand.” That’s technically correct and completely inadequate. POTS affects virtually every system the autonomic nervous system touches – which is nearly everything. Patients often feel dismissed because they present with a long, seemingly unrelated list of symptoms that no single specialist can explain. Here’s what POTS can actually look like:

Cardiovascular

• Rapid heart rate upon standing (the defining symptom)
• Heart palpitations, including at rest in hyperadrenergic POTS
• Chest pain or tightness (usually non-cardiac)
• Blood pooling in hands and feet (they may turn red, purple, or mottled – called “dependent acrocyanosis”)

Neurological and Cognitive

• Brain fog – difficulty concentrating, word-finding problems, feeling “spacey.” This is often the most disabling symptom, more so than the tachycardia itself
• Lightheadedness and pre-syncope (feeling like you’re about to faint)
• Actual fainting (syncope) in about 30% of patients
• Headaches, including migraine
• Visual disturbances (tunnel vision, blurring upon standing)
• Tremor and shakiness

Gastrointestinal

• Nausea (extremely common, often worst in the morning)
• Gastroparesis or slow gastric motility
• Bloating and early fullness
• Constipation or diarrhea (or alternating)
• Abdominal pain

Temperature and Autonomic Dysregulation

• Heat intolerance – symptoms worsen significantly in warm environments
• Abnormal sweating (too much or too little)
• Cold extremities despite warm core temperature
• Difficulty regulating body temperature

General

• Profound fatigue – not just tiredness but a bone-deep exhaustion that rest doesn’t resolve
• Exercise intolerance – feeling terrible during and after physical activity despite wanting to be active
• Sleep disturbance – difficulty falling asleep, non-restorative sleep, insomnia
• Symptom flares with menstrual cycles (many women report significant worsening in the week before their period)

Post-COVID POTS: The Surge That Changed Everything

Before 2020, POTS was an obscure diagnosis known mainly to cardiologists and neurologists with a special interest in autonomic disorders. Then COVID-19 happened, and the POTS population exploded.

Studies estimate that 2-14% of COVID-19 survivors develop POTS or POTS-like symptoms, with higher rates among those with more severe acute infections and those who develop long COVID. A 2022 study in Nature Cardiovascular Research found that POTS diagnoses increased approximately 50% in the post-pandemic period compared to pre-pandemic rates. Some autonomic disorder clinics report that post-COVID POTS now accounts for the majority of their new referrals.

The proposed mechanisms connecting COVID-19 to POTS include:

• Autoimmune autonomic damage: COVID-19 may trigger autoantibodies against autonomic receptors (anti-adrenergic and anti-muscarinic antibodies have been found in post-COVID POTS patients)
• Small fiber neuropathy: Direct viral damage or inflammatory damage to the small nerve fibers controlling blood vessel tone
• Deconditioning: Prolonged illness and bed rest leading to cardiovascular deconditioning and reduced blood volume
• Mast cell activation: COVID-19 appears to trigger or worsen MCAS, which in turn can contribute to POTS
• Endothelial dysfunction: Damage to the blood vessel lining affecting vascular reactivity

The silver lining of this surge is increased research funding, medical awareness, and clinical expertise. Post-COVID POTS patients often respond to the same treatments as pre-COVID POTS patients, and many experience gradual improvement over 12-24 months.

Non-Pharmacological Treatment: The Foundation

Before reaching for medications, the cornerstone of POTS management is a set of lifestyle modifications that sound deceptively simple but can make a dramatic difference. Every POTS specialist starts here – not because they’re dismissing your symptoms, but because these interventions genuinely work and medications work better on top of them.

Salt Loading: 8-10 Grams Per Day

This runs completely counter to standard cardiovascular advice, which is exactly why many POTS patients never hear it. In POTS, the problem is often low blood volume and excessive vasodilation – more salt helps the body retain fluid and expand blood volume. The target is 8-10 grams of sodium per day, which is roughly 3-4 times what the average American consumes. Strategies include salt tablets (1g tablets, 2-3 with each meal), electrolyte drinks (look for products with 1,000+ mg sodium per serving), salty foods, and adding salt liberally to meals. Note: this should be done under medical supervision, and patients with kidney disease, heart failure, or hypertension should work closely with their physician.

Fluid Intake: 2-3 Liters Per Day

Salt without adequate water doesn’t work. The goal is 2-3 liters of fluid daily, ideally with electrolytes rather than plain water (plain water is actually less effective at expanding blood volume because it’s excreted more quickly). Many patients find it helpful to front-load fluids in the morning, drinking 500 mL of an electrolyte solution before getting out of bed. Some patients with severe POTS benefit from periodic IV saline infusions (typically 1-2 liters of normal saline), though this is a temporizing measure rather than a long-term solution.

Compression Garments

Compression stockings (waist-high, 30-40 mmHg) and abdominal binders reduce blood pooling in the lower body and abdomen. The key insight: knee-high compression stockings don’t work well for POTS because they don’t compress the abdominal venous reservoir, which holds the most pooled blood. Waist-high compression or the combination of thigh-high stockings plus an abdominal binder provides significantly better results. Medical-grade compression garments can be uncomfortable, especially in warm weather, but many patients report they’re significant.

Exercise: The Levine Protocol

Exercise is arguably the single most effective treatment for POTS – and also one of the hardest to implement, because exercise itself triggers symptoms. The Levine Protocol (also called the CHOP protocol for the modified version developed at Children’s Hospital of Philadelphia) is a carefully structured, progressive exercise program specifically designed for POTS patients.

The key principles:

• Start recumbent: Begin with exercises that don’t require standing – recumbent bike, rowing machine, swimming. This lets you train your cardiovascular system without triggering orthostatic symptoms.
• Progress slowly: The program spans 3-6 months with gradual increases in duration, intensity, and upright exercise.
• Consistency over intensity: 3-4 sessions per week of moderate exercise is far better than 1 session of intense exercise.
• Expect setbacks: Many patients feel worse before they feel better (often in weeks 2-4). This is expected and not a reason to stop.
• Upright exercise comes later: Walking, jogging, and standing exercises are introduced only after a base of recumbent fitness is established.

A landmark 2011 study by Dr. Benjamin Levine’s group found that after 3 months of this protocol, 71% of patients no longer met POTS diagnostic criteria. It’s not a cure – many patients need to maintain the exercise program indefinitely – but it’s the closest thing we have to a treatment that addresses the underlying physiology.

Other Lifestyle Strategies

• Elevate the head of your bed 4-6 inches (not just pillows – the entire head of the bed). This reduces nighttime natriuresis (salt/water loss through urine) and improves morning symptoms.
• Eat smaller, more frequent meals – large meals divert blood to the gut and worsen pooling.
• Avoid prolonged standing – if you must stand, shift your weight, cross your legs, or clench your muscles (physical counter-maneuvers).
• Manage heat exposure – cool showers rather than hot, avoid prolonged sun exposure, use cooling vests in summer.
• Limit alcohol – it causes vasodilation and dehydration, both of which worsen POTS.
• Rise slowly – sit on the edge of the bed for 1-2 minutes before standing, especially in the morning.

Medications for POTS: A Comprehensive Comparison

When lifestyle modifications aren’t enough – and for many patients, they aren’t – medications can provide significant additional benefit. No medication is FDA-approved specifically for POTS (it’s an orphan condition), so all use is off-label. Treatment is typically guided by the patient’s predominant subtype and symptoms.

Emerging and Investigational Therapies

The POTS research field is expanding rapidly, driven by both post-COVID interest and improved understanding of the autoimmune mechanisms underlying many cases. Several therapies are showing early promise:

IVIG (Intravenous Immunoglobulin)

For patients with demonstrated autoimmune markers (autoantibodies against adrenergic or muscarinic receptors), IVIG has shown benefit in case series and small pilot studies. The rationale is straightforward: if POTS is driven by autoantibodies damaging autonomic nerves, then suppressing or neutralizing those antibodies should improve symptoms. Published case series report significant improvement in 60-70% of carefully selected patients with autoimmune POTS. However, IVIG is expensive ($5,000-$10,000+ per infusion, typically monthly), carries risks (headache, aseptic meningitis, allergic reactions, blood clots), and is extremely difficult to obtain insurance coverage for in POTS. Larger controlled trials are needed before this can be widely recommended.

Low-Dose Naltrexone (LDN)

Low-dose naltrexone (1.5-4.5 mg at bedtime) has gained attention in the POTS community for its potential immunomodulatory and anti-neuroinflammatory effects. While there are no randomized controlled trials specifically in POTS, LDN has shown benefit in other conditions with overlapping mechanisms (fibromyalgia, chronic fatigue syndrome, autoimmune conditions). Many POTS patients and some specialists report symptomatic improvement, particularly in fatigue and brain fog. Its favorable side effect profile and low cost make it a reasonable option for patients with suspected autoimmune or neuroinflammatory POTS, though evidence remains anecdotal.

Stellate Ganglion Block

The stellate ganglion is a sympathetic nerve bundle in the neck. Injecting it with local anesthetic (a procedure originally developed for pain management) temporarily “resets” sympathetic nervous system activity. Case series in POTS patients – particularly those with hyperadrenergic features – have reported improvements lasting weeks to months after a single injection. The proposed mechanism is sympathetic nervous system “rebalancing” following the temporary blockade. This is a minimally invasive, low-risk procedure that may be particularly relevant for hyperadrenergic and post-COVID POTS. Clinical trials are underway.

POTS vs. Similar Conditions: How to Tell the Difference

POTS is commonly confused with several other conditions, and accurate diagnosis matters because treatments differ significantly. Here’s how they compare:

Frequently Asked Questions

What does a POTS episode feel like?

A POTS episode – sometimes called a “flare” – typically begins within moments of standing and builds over seconds to minutes. Patients describe it as a rushing sensation in the head, a sudden awareness of their heartbeat pounding hard and fast, a wave of lightheadedness or tunnel vision, and an overwhelming urge to sit or lie down. Many people feel flushed, nauseated, and shaky. Some describe it as feeling like you’re going to faint even though you don’t always actually pass out. The cognitive effects are particularly disorienting – thoughts become foggy and slow, words are hard to find, and there’s a sense of being “disconnected” from your surroundings. During severe episodes, patients may experience chest pressure, shortness of breath, profuse sweating, and a profound sense of dread that mimics a panic attack but is driven by cardiovascular physiology rather than psychological distress. Episodes can last minutes to hours, and the fatigue and brain fog afterward can persist for the rest of the day.

Can POTS go away?

Yes, in some cases. POTS is not always a permanent condition. Research suggests that approximately 50-60% of patients with post-viral POTS (including post-COVID POTS) experience significant improvement within 2-5 years, with some achieving complete resolution. Adolescent-onset POTS has particularly favorable outcomes – many teenagers improve or recover by their early twenties. Patients who respond well to the Levine exercise protocol may achieve remission as long as they maintain their fitness. However, some patients – particularly those with underlying Ehlers-Danlos syndrome, progressive small fiber neuropathy, or autoimmune drivers – have a more chronic course. The honest answer is: many patients improve substantially, some recover fully, and some manage a chronic condition with varying degrees of success. The trajectory is difficult to predict at the outset.

Is POTS a disability?

POTS can absolutely be disabling – some patients are unable to work, attend school, or perform basic daily activities. Studies have shown that POTS patients report quality-of-life scores comparable to those of patients with heart failure or COPD. Whether POTS qualifies for formal disability benefits depends on the severity of your symptoms and their documented impact on your ability to work. POTS is recognized by the Social Security Administration as a potentially qualifying condition, but approval typically requires detailed documentation including tilt table results, treatment records showing failed therapies, and functional assessments demonstrating inability to maintain upright posture for the duration required by employment. A physician letter specifically addressing how POTS limits standing, cognitive function, and sustained activity is critical. Many patients benefit from working with a disability attorney experienced in autonomic disorders.

Can COVID cause POTS?

Yes. COVID-19 is now one of the most common triggers for new-onset POTS. Studies estimate that 2-14% of COVID-19 survivors develop POTS, with higher rates among those with long COVID. The mechanism likely involves a combination of autoimmune damage to autonomic nerves (autoantibodies have been identified), small fiber neuropathy triggered by the infection, cardiovascular deconditioning from prolonged illness, and possible direct viral effects on the autonomic nervous system. Post-COVID POTS can develop days to months after the initial infection, even after mild cases. The good news is that post-COVID POTS appears to respond to the same treatments as other forms of POTS, and preliminary data suggests a meaningful percentage of patients improve over 12-24 months. If you developed persistent tachycardia, exercise intolerance, brain fog, or lightheadedness after a COVID infection, request a standing heart rate test from your physician.

Can you exercise with POTS?

Yes – and you should, though the approach matters enormously. Exercise is one of the most effective treatments for POTS, but exercising the wrong way can make symptoms worse and trigger prolonged flares. The key principles: start recumbent (recumbent bike, rowing, swimming – anything that doesn’t require standing), start low (even 5-10 minutes is a valid starting point), and progress gradually over months, not weeks. The Levine Protocol provides a structured framework – studies show that after 3 months of consistent recumbent exercise progressing to upright exercise, most POTS patients experience significant improvement in heart rate control, exercise tolerance, and symptoms. Avoid high-intensity standing exercise early in your program, exercise in cool environments, hydrate aggressively before and during sessions, and don’t push through severe symptoms. Many patients find that morning exercise is harder (POTS symptoms tend to be worst in the morning) and afternoon sessions are more tolerable. If you’ve been largely sedentary due to POTS, working with a physical therapist experienced in autonomic disorders can help you build a safe program.

What kind of doctor treats POTS?

POTS is typically managed by cardiologists (especially electrophysiologists) or neurologists with expertise in autonomic disorders. Some POTS centers have multidisciplinary teams including cardiologists, neurologists, physical therapists, and psychologists. Because POTS often coexists with other conditions (EDS, MCAS, small fiber neuropathy), many patients benefit from coordinated care across multiple specialists. Finding a physician who is specifically experienced with POTS is important – unfortunately, many general cardiologists and neurologists have limited familiarity with the condition. Dysautonomia International (dysautonomiainternational.org) maintains a physician directory that can help identify specialists in your area.

Is POTS hereditary?

There is growing evidence of a genetic component in some forms of POTS. Studies have found familial clustering, and first-degree relatives of POTS patients are more likely to have POTS or related autonomic dysfunction than the general population. When POTS occurs in the context of Ehlers-Danlos syndrome (which has strong genetic components), there may be a hereditary predisposition to developing POTS. However, POTS itself is not a simple genetic condition – most cases likely result from an environmental trigger (virus, trauma, surgery, puberty) acting on a genetically susceptible individual. If POTS runs in your family, it’s worth being aware of the symptoms but not inevitable that you will develop it.

Living with POTS: Practical Strategies That Make a Difference

Beyond the medical management, there are day-to-day strategies that POTS patients learn through experience:

• Get a shower stool. Showers are one of the most common triggers for POTS episodes (heat + standing). Sitting makes them manageable.
• Keep electrolytes everywhere – by the bed, in your bag, at your desk. Rapid oral rehydration at the first sign of a flare can abort mild episodes.
• Learn counter-maneuvers: Crossing your legs and squeezing your thigh muscles, making fists, or squatting can temporarily increase blood return to the heart during symptomatic episodes.
• Track your triggers. Many POTS patients find that heat, large meals, alcohol, menstrual cycles, and inadequate sleep are reliable triggers. Identifying your personal patterns allows proactive management.
• Plan your day around your symptoms. Most POTS patients have better afternoons than mornings. Schedule important activities accordingly.
• Communicate with your employer or school. POTS can qualify for workplace accommodations (standing desk that converts to sitting, flexible hours, hydration and bathroom breaks) under the ADA. Schools can provide 504 plans.
• Connect with the community. POTS can be isolating, and connecting with others who understand the condition – through organizations like Dysautonomia International or The Dysautonomia Project – provides both emotional support and practical tips from lived experience.

The Prognosis: Where Do We Go From Here?

POTS is not a fatal condition, but it can profoundly impact quality of life. The good news is that the trajectory for most patients is one of gradual improvement – with appropriate treatment, most people achieve a meaningful increase in function and quality of life, even if they don’t return to their pre-POTS baseline. The post-COVID research boom is accelerating our understanding of autonomic dysfunction and driving development of new therapies. The days of “it’s all in your head” are ending, replaced by measurable biomarkers, targeted treatments, and a growing community of physicians who take this condition seriously.

If you’ve just been diagnosed, know this: the first 6-12 months are typically the hardest, both symptomatically and emotionally. Treatment takes time to optimize, and the lifestyle changes require adjustment. But most patients find a combination of strategies that allows them to live meaningfully – even if differently – with this condition. You are not imagining it. It is not anxiety. And you are not alone.

Related Reading

• Small Fiber Neuropathy: Diagnosis, Causes, and Treatment
• Mast Cell Activation Syndrome (MCAS): The Complete Guide
• Ehlers-Danlos Syndrome: Understanding the Connective Tissue Disorder
• Brain Fog: Causes, Mechanisms, and Evidence-Based Solutions
• Low-Dose Naltrexone (LDN): Uses, Evidence, and Practical Guide